Bender Robert & Associates’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$624K	Buy	+34,701	New	+$696K	0.15%	30
2025 Q4	–	Sell	-34,701	Closed	-$692K	–	46
2025 Q3	$692K	Hold	34,701	–	–	0.15%	28
2025 Q2	$475K	Buy	+34,701	New	+$333K	0.11%	32
2025 Q1	–	Sell	-34,701	Closed	-$370K	–	48
2024 Q4	$370K	Buy	+34,701	New	+$415K	0.09%	36
2024 Q2	–	Sell	-34,701	Closed	-$521K	–	83
2024 Q1	$521K	Hold	34,701	–	–	0.12%	36
2023 Q4	$521K	Hold	34,701	–	–	0.13%	38
2023 Q3	$486K	Hold	34,701	–	–	0.14%	38
2023 Q2	$359K	Hold	34,701	–	–	0.1%	40
2023 Q1	$321K	Buy	+34,701	New	+$319K	0.1%	45
2022 Q4	–	Sell	-41,131	Closed	-$342K	–	52
2022 Q3	$342K	Hold	41,131	–	–	0.13%	43
2022 Q2	$337K	Buy	+41,131	New	+$282K	0.13%	42
2021 Q2	–	Sell	-31,131	Closed	-$606K	–	54
2021 Q1	$606K	Buy	+31,131	New	+$661K	0.2%	37